These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2874293)

  • 1. HLA-DR in Lyme borreliosis.
    Kristoferistsch W; Mayr WR; Partsch H; Neumann R; Stanek G
    Lancet; 1986 Aug; 2(8501):278. PubMed ID: 2874293
    [No Abstract]   [Full Text] [Related]  

  • 2. No association with HLA class II alleles in Swedish patients with cutaneous manifestations of Lyme borreliosis.
    Olsson I; Asbrink E; Olerup O
    Acta Derm Venereol; 1994 Jul; 74(4):262-5. PubMed ID: 7976082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HLA-DQ antigens on keratinocytes in Borrelia spirochete-induced skin lesions.
    Tjernlund U; Scheynius A; Asbrink E; Hovmark A
    Scand J Immunol; 1986 Mar; 23(3):383-8. PubMed ID: 2419972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.
    Wokke JH; van Doorn PA; Brand A; Schreuder GM; Vermeulen M
    J Neurol; 1988 Sep; 235(7):415-7. PubMed ID: 3265432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyme-borreliosis and possible association with HLA-antigens.
    Pflüger KH; Reimers CD; Neubert U; Meisel C; Trapp B; Leititis J; Völker B; Münchhoff P; Litzenberger J; Holthausen H
    Tissue Antigens; 1989 Mar; 33(3):375-81. PubMed ID: 2741164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is chronic Lyme borreliosis chronic?
    Aberer E; Koszik F; Silberer M
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S64-70. PubMed ID: 9233667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of class II molecules on epidermal Langerhans cells in Lyme borreliosis.
    Silberer M; Koszik F; Stingl G; Aberer E
    Br J Dermatol; 2000 Oct; 143(4):786-94. PubMed ID: 11069457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR in meningopolyneuritis of Garin-Bujadoux-Bannwarth: contrast to Lyme disease?
    Kristoferitsch W; Mayr WR
    J Neurol; 1984; 231(5):271-2. PubMed ID: 6596406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology and immunophenotype of acrodermatitis chronica atrophicans correlated with ospA and ospC genotypes of Borrelia species.
    Brandt FC; Ertas B; Falk TM; Metze D; Böer-Auer A
    J Cutan Pathol; 2015 Oct; 42(10):674-92. PubMed ID: 26156537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lyme disease and HLA-DR antigens: relation between HLA-DR2 and HLA-DR4].
    Májský A; Bojar M; Jirous J
    Vnitr Lek; 1988 Jan; 34(1):54-9. PubMed ID: 3258452
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles.
    Steere AC; Dwyer E; Winchester R
    N Engl J Med; 1990 Jul; 323(4):219-23. PubMed ID: 2078208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic atrophic acrodermatitis as a late manifestation of Lyme borreliosis].
    Liszkay G; Lakos A; Vecsei E; Daróczy J
    Orv Hetil; 1988 Oct; 129(40):2143-5. PubMed ID: 3174136
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased expression of Fas receptor and Fas ligand in the culture of the peripheral blood mononuclear cells stimulated with Borrelia burgdorferi sensu lato.
    Grygorczuk S; Osada J; Moniuszko A; Świerzbińska R; Kondrusik M; Zajkowska J; Dunaj J; Dąbrowska M; Pancewicz S
    Ticks Tick Borne Dis; 2015 Mar; 6(2):189-97. PubMed ID: 25541498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin levels in patients with Lyme borreliosis.
    Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acrodermatitis chronica atrophicans].
    Wittmann D; Heppt M; Ruzicka T
    MMW Fortschr Med; 2016 Mar; 158(6):64, 66-7. PubMed ID: 27084166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acrodermatitis chronica atrophicans--a borreliosis!].
    Preac-Mursic V; Wilske B; Herzer P; Schierz G; Bauer M
    Hautarzt; 1985 Dec; 36(12):691-3. PubMed ID: 4086299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence survey of borreliosis in children with chronic arthritis in British Columbia, Canada.
    Banerjee S; Banerjee M; Cimolai N; Malleson P; Proctor E
    J Rheumatol; 1992 Oct; 19(10):1620-4. PubMed ID: 1464879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.